Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Irhythm Technologies Inc    IRTC

IRHYTHM TECHNOLOGIES INC

(IRTC)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Irhythm Technologies : Collaborating With Verily to Help Atrial Fibrillation Patients

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/04/2019 | 05:39pm EDT

By Stephen Nakrosis

iRhythm Technologies said Wednesday it would collaborate with Alphabet Verily to improve screening, diagnosis and management of patients with atrial fibrillation.

About one-third of people with atrial fibrillation are unaware they have it, the companies said, and about 20% of those who experience stroke due to atrial fibrillation weren't diagnosed until they had a stroke.

"The iRhythm and Verily collaboration aims to address this significant, underserved population at risk for asymptomatic or silent AFib," the companies said.

Under the terms of the deal, iRhythm will make an upfront payment to Verily of $5 million and potential milestone payments of up to $12.75 million upon the achievement of various development and regulatory milestones.

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET 0.41% 1240.03 Delayed Quote.18.67%
IRHYTHM TECHNOLOGIES INC -0.24% 78.62 Delayed Quote.13.15%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IRHYTHM TECHNOLOGIES INC
09/10IRHYTHM TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Financi..
AQ
09/10iRhythm Technologies Announces Closing of Follow-on Public Offering and Full ..
GL
09/05iRhythm Technologies Announces Pricing of Public Offering of Common Stock
GL
09/04IRHYTHM TECHNOLOGIES : Collaborating With Verily to Help Atrial Fibrillation Pat..
DJ
09/04IRHYTHM TECHNOLOGIES : Announces Proposed Public Offering of Common Stock
AQ
09/04IRHYTHM TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Financi..
AQ
09/04iRhythm Announces Collaboration with Verily to Develop Health Management Solu..
GL
08/27IRHYTHM TECHNOLOGIES : to Present at the 17th Annual Morgan Stanley Global Healt..
AQ
08/06IRHYTHM TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
07/31IRHYTHM TECHNOLOGIES, INC. : Results of Operations and Financial Condition, Fina..
AQ
More news
Financials (USD)
Sales 2019 216 M
EBIT 2019 -38,8 M
Net income 2019 -38,6 M
Debt 2019 6,00 M
Yield 2019 -
P/E ratio 2019 -50,8x
P/E ratio 2020 -101x
EV / Sales2019 9,66x
EV / Sales2020 7,28x
Capitalization 2 076 M
Chart IRHYTHM TECHNOLOGIES INC
Duration : Period :
Irhythm Technologies Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IRHYTHM TECHNOLOGIES INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 101,29  $
Last Close Price 78,62  $
Spread / Highest target 59,0%
Spread / Average Target 28,8%
Spread / Lowest Target -4,60%
EPS Revisions
Managers
NameTitle
Kevin M. King President, Chief Executive Officer & Director
Abhijit Y. Talwalkar Chairman
Karim Karti Chief Operating Officer
Matthew C. Garrett Chief Financial & Accounting Officer
Mark J. Day Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IRHYTHM TECHNOLOGIES INC13.15%2 076
THERMO FISHER SCIENTIFIC33.00%119 202
DANAHER CORPORATION37.45%101 163
INTUITIVE SURGICAL9.25%60 303
BOSTON SCIENTIFIC CORPORATION18.31%58 240
EDWARDS LIFESCIENCES CORPORATION43.30%45 649